-20°C, sealed storage, away from moistur In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
产品详情
Zabofloxacin hydrochloride (DW-224a) 是一种有效的、对细菌 II 型和 IV 型拓扑异构酶 (type II and IV topoisomerases) 有效的抑制剂。Zabofloxacin hydrochloride 对革兰氏阳性致病菌包括金黄色葡萄球菌、化脓性链球菌和肺炎链球菌有良好的抗菌活性。Zabofloxacin hydrochloride 是一种新型氟萘啶酮喹诺酮类抗生素,被认为是研究喹诺酮易感 (QSSP) 和喹诺酮耐药淋病 (QRSP) 的替代试剂。
生物活性
Zabofloxacin hydrochloride (DW-224a) is a potent and seletive inhibitor of the bacterial type II and IV topoisomerases. Zabofloxacin hydrochloride has excellent activity against gram-positive pathogens including Steptococcus aureus, Streptococcus pyogenes and S.pneumonia. Zabofloxacin hydrochloride is a novel fluoronaphthyridone quinolone that is considered as an alternative antibiotic for treatment of quinolone-susceptible (QSSP) and quinolone-resistant gonorrhea (QRSP).
性状
Solid
IC50 & Target[1][2]
Topoisomerase I Topoisomerase II
体外研究(In Vitro)
Zabofloxacin shows a highly potent in vitro activity against clinical isolates of penicillin-sensitive S. pneumoniae (minimum inhibitory concentration, MIC90: 0.03 mg/L) and penicillin-resistant S. pneumoniae (MIC90: 0.03 mg/L). Against quinolone-resistant S. pneumoniae , zabofloxacin (MIC90: 1 mg/L) is more active than ciprofloxacin, sparfloxacin, and moxifloxacin. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
-20°C, sealed storage, away from moistur In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
ClinicalTrial
参考文献
[1]. Park HS, et al. Antimicrobial Activity of Zabofloxacin against Clinically Isolated Streptococcus pneumoniae. Molecules. 2016 Nov 17;21(11). pii: E1562.
溶解度数据
In Vitro: DMSO : 6.67 mg/mL (15.23 mM; ultrasonic and warming and heat to 60°C)配制储备液